Trial ID: | L0704 |
Source ID: | NCT04364360
|
Associated Drug: |
Sulforaphane
|
Title: |
Fatty Acid MetabOlism in Individuals Undergoing Sulforaphane Supplementation (FAMOUS)
|
Acronym: |
FAMOUS
|
Status: |
Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Non-Alcoholic Fatty Liver Disease;Obesity;Metabolic Syndrome
|
Interventions: |
Dietary Supplement: Sulforaphane extract
|
Outcome Measures: |
Change in whole-body fatty acid oxidationChange in liver fat content;Change in hepatic fatty acid partitioning;Change in glycemic control
|
Sponsor/Collaborators: |
University of Oxford
|
Gender: |
All
|
Age: |
18 Years65 Years
|
Phases: |
Not applicable
|
Enrollment: |
60
|
Study Type: |
Interventional
|
Study Designs: |
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
|
Start Date: |
06/04/2020
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
10 May 2021
|
Locations: |
United Kingdom
|
URL: |
https://clinicaltrials.gov/show/NCT04364360
|